03:41 AM EDT, 03/21/2025 (MT Newswires) -- Bobak R. Azamian, Director, President, Chief Executive Officer and Board Chair, on March 18, 2025, sold 24,216 shares in Tarsus Pharmaceuticals ( TARS ) for $1,163,050. Following the Form 4 filing with the SEC, Azamian has control over a total of 883,741 common shares of the company, with 53,635 shares held directly and 830,106 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000181979025000055/xslF345X05/wk-form4_1742521708.xml